Minerva Biotechnologies

Minerva Biotechnologies

Biotechnology Waltham, Massachusetts, United States 18 employees
Employees
18
Contacts
3
Emails
3
Phones
2

Minerva Biotechnologies Overview

Headquarters
Waltham, Massachusetts, United States
Phone Number
Available in AeroLeads
Website
minervabio.com
Industry
Biotechnology
Employees
18
Founded
1999
Funding
4.5M
Company Email
Available in AeroLeads

About Minerva Biotechnologies

Minerva Biotechnologies is a clinical stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine. NCT04020575 is Minerva’s first-in-human trial of huMNC2-CAR44, a CAR T that targets the MUC1* growth factor receptor, for the treatment of metastatic breast cancers, 95% of which express a MUC1*. We are now expanding the current clinical trial to include our second CAR-T product that greatly increases persistence. The Company is rapidly accelerating its pipeline that includes next-gen CAR-T products, a straight antibody therapeutic and a small molecule therapeutic which are both for the treatment of cancer metastasis. Our track record of scientific breakthroughs is a testament to our visionary team and our collaborative culture. Join us in changing the world.

Minerva Biotechnologies Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Minerva Biotechnologies Org Chart

Sample employees and titles
Name Title Contact
Ron Axelrod COO
Email Phone
Trevor Grant Ph.d. Scientist with Expertise
Email Phone
Robert M. Graduate Student at Tufts University
View
Andrew Stewart Head of Research and Development
Email

Employees by Management Level

Individual contributor 9 profiles
Executive 1 profile
VP / Head 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 7 7 2

Minerva Biotechnologies Tech Stack

Data / AI 5 profiles

Compare Similar Companies to Minerva Biotechnologies